摘要:
The invention relates to a process for the preparation of onium alkylsulfates by reaction of an onium halide with a symmetrically substituted dialkyl sulfate, in which the alkyl group can have 1 to 14 C atoms, with an asymmetrically substituted dialkyl sulfate, in which one alkyl group can have 4 to 20 C atoms and the second alkyl group denotes methyl or ethyl, with an alkyl trialkylsilyl sulfate, with an alkyl acyl sulfate or with an alkyl sulfonyl sulfate, where the reaction with a dialkyl sulfate is carried out at room temperature.
摘要:
The present invention provides novel pyrazoles that are useful as cannabinoid receptor antagonists and pharmaceutical compositions thereof and methods of using the same for treating obesity, diabetes, hepatic disorders, and/or cardiometabolic disorders.
摘要:
The present invention relates to substituted pyrazoline compounds, methods for their preparation, medicaments comprising these compounds as well as their use for the preparation of a medicament for the treatment of humans and animals, especially in dyslipidaemia.
摘要:
The present invention relates to fluorinated dihydropyrazole compounds that are useful for treating cellular proliferative diseases, for treating disorders associated with KSP kinesin activity, and for inhibiting KSP kinesin. The invention also related to compositions which comprise these compounds, and methods of using them to treat cancer in mammals.
摘要:
A near infrared fluorescent contrast agent comprising a compound having three or more sulfonic acid groups in a molecule, and a method of fluorescence imaging comprising introducing the near infrared fluorescent contrast agent of the present invention into a living body, exposing the body to an excitation light, and detecting near infrared fluorescence from the contrast agent. The near infrared fluorescent contrast agent of the present invention is excited by an excitation light and emits near infrared fluorescence. This infrared fluorescence is superior in transmission through biological tissues. Thus, detection of lesions in the deep part of a living body has been made possible. In addition, the inventive contrast agent is superior in water solubility and low toxic, and therefore, it can be used safely.
摘要:
The present invention provides novel pyrazoles that are useful as cannabinoid receptor antagonists and pharmaceutical compositions thereof and methods of using the same for treating obesity, diabetes, and/or cardiometabolic disorders.
摘要:
The present invention relates to prodrugs of pyrazoline compounds of formula I, methods for their preparation, medicaments comprising these compounds as well as their use for the preparation of a medicament for the treatment of humans and animals.
摘要:
The present invention relates to substituted pyrazoline compounds, methods for their preparation, medicaments comprising these compounds as well as their use for the preparation of a medicament for the treatment of humans and animal.
摘要:
Novel 5-hydroxypyrazolines of the formula I in which the substituents are as defined below: B is phenyl, naphthyl or 5- or 6-membered hetaryl which contains one to four heteroatoms from the group consisting of O, N and S; A is C═O, C═S or SO2; W is CX1X2; X1, X2 are hydrogen, fluorine, chlorine or bromine; R1 is alkyl, haloalkyl, alkenyl, haloalkenyl, alkynyl or haloalkynyl, cycloalkyl, cycloalkenyl, cycloalkynyl, phenyl, 5- or 6-membered heterocyclyl or hetaryl which contains one to four heteroatoms from the group consisting of O, N and S; R2 is hydrogen or alkyl; R3 is hydrogen, nitro, cyano, alkyl, haloalkyl, alkoxy, haloalkoxy, alkenyl, haloalkenyl, alkynyl, haloalkynyl or NR′2, where R′ independently of one another are hydrogen or alkyl; R4 is hydrogen, halogen, nitro, cyano, NR′2, alkyl, haloalkyl, COOR′ or 5- or 6-membered hetaryl or heterocyclyl; where the variables mentioned above may be substituted according to the description; processes for their preparation, their use for controlling harmful fungi and compositions comprising them.
摘要翻译:式I的新型5-羟基吡唑啉,其中取代基如下所定义:B是苯基,萘基或含有一至四个由O,N和S组成的组的杂原子的5-或6-元杂芳基; A是C-O,C-S或SO 2。 W是CX 1,X 2, X 1,X 2是氢,氟,氯或溴; R 1是烷基,卤代烷基,烯基,卤代烯基,炔基或卤代炔基,环烷基,环烯基,环炔基,苯基,5-或6-元杂环基或杂芳基,其含有一至四个 O,N和S; R 2是氢或烷基; R 3是氢,硝基,氰基,烷基,卤代烷基,烷氧基,卤代烷氧基,烯基,卤代烯基,炔基,卤代炔基或NR'2,其中R'彼此独立地 是氢或烷基; R 4是氢,卤素,硝基,氰基,NR'2,烷基,卤代烷基,COOR'或5-或6-元杂芳基或杂环基; 其中上述变量可以根据描述被替代; 其制备方法,它们用于控制有害真菌的用途和包含它们的组合物。